BioGaia AB (BIOGY)
11.50
0.00 (0.00%)
USD |
OTCM |
Sep 27, 16:00
BioGaia Total Assets (Quarterly): 179.09M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 179.09M |
| March 31, 2024 | 232.80M |
| December 31, 2023 | 231.77M |
| September 30, 2023 | 211.10M |
| June 30, 2023 | 198.64M |
| March 31, 2023 | 224.47M |
| December 31, 2022 | 212.42M |
| September 30, 2022 | 194.07M |
| June 30, 2022 | 203.82M |
| March 31, 2022 | 241.48M |
| December 31, 2021 | 235.23M |
| September 30, 2021 | 223.77M |
| June 30, 2021 | 227.27M |
| March 31, 2021 | 223.24M |
| December 31, 2020 | 233.65M |
| September 30, 2020 | 79.40M |
| June 30, 2020 | 76.19M |
| March 31, 2020 | 71.55M |
| December 31, 2019 | 71.26M |
| September 30, 2019 | 65.29M |
| June 30, 2019 | 64.37M |
| March 31, 2019 | 75.92M |
| December 31, 2018 | 73.49M |
| September 30, 2018 | 67.31M |
| June 30, 2018 | 65.45M |
| Date | Value |
|---|---|
| March 31, 2018 | 74.96M |
| December 31, 2017 | 70.45M |
| September 30, 2017 | 64.43M |
| June 30, 2017 | 56.71M |
| March 31, 2017 | 63.11M |
| December 31, 2016 | 53.93M |
| September 30, 2016 | 52.65M |
| June 30, 2016 | 48.78M |
| March 31, 2016 | 55.56M |
| December 31, 2015 | 56.27M |
| September 30, 2015 | 54.00M |
| June 30, 2015 | 53.71M |
| March 31, 2015 | 55.40M |
| December 31, 2014 | 53.61M |
| September 30, 2014 | 53.78M |
| June 30, 2014 | 58.80M |
| March 31, 2014 | 75.03M |
| December 31, 2013 | 59.81M |
| September 30, 2013 | 56.68M |
| June 30, 2013 | 56.65M |
| March 31, 2013 | 82.50M |
| December 31, 2012 | 79.52M |
| September 30, 2012 | 80.63M |
| June 30, 2012 | 77.09M |
| March 31, 2012 | 96.39M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
65.29M
Minimum
Sep 2019
241.48M
Maximum
Mar 2022
181.82M
Average
211.76M
Median
Total Assets (Quarterly) Benchmarks
| Abliva AB | 7.132M |
| Karolinska Development AB | 117.25M |
| Calliditas Therapeutics AB | 164.63M |
| Oncopeptides AB | 27.02M |
| BioInvent International AB | 112.97M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 30.66M |
| Shareholders Equity (Quarterly) | 148.43M |
| Current Ratio | 6.489 |